Cost-effectiveness analysis of contemporary first-line (1L) agents in locally advanced/metastatic urothelial carcinoma (la/mUC)

被引：0

作者：

Naqvi, Syed Arsalan Ahmed

Faisal, Kunwer Sufyan

Raina, Ammad

Khakwani, Kaneez Zahra Rubab

Bin Riaz, Zaryab

Shah, Vishal S.

Cobran, Ewan Kemar

Singh, Parminder

Hussain, Syed A.

Bryce, Alan Haruo

Bin Riaz, Irbaz

机构：

[1] Mayo Clin, Div Hematol & Med Oncol, Phoenix, AZ USA

[2] Ziauddin Med Univ, Karachi, Pakistan

[3] Canyon Vista Med Ctr, Sierra Vista, AZ USA

[4] Univ Arizona, Tucson, AZ USA

[5] Rashid Latif Med Coll, Lahore, Pakistan

[6] Mayo Clin, Phoenix, AZ USA

[7] Mayo Clin, Coll Med & Sci, Scottsdale, AZ USA

[8] Univ Sheffield, Sheffield, England

[9] Sheffield Teaching Hosp, Sheffield, England

[10] City Hope Natl Med Ctr, Phoenix, AZ USA

[11] Mayo Clin, Scottsdale, AZ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4591

引用

页数：1